What the Research Actually Says About Supplements for Eczema

What the Research Actually Says About Supplements for Eczema

Eczema — formally known as atopic dermatitis — is not just a skin problem. It's a systemic inflammatory condition rooted in immune dysregulation, a compromised skin barrier, and, increasingly, gut health. For millions of Americans, it means chronic itch, disrupted sleep, and a constant search for relief beyond topical steroids.

The supplement aisle offers no shortage of promises, but what does the clinical literature actually support? This article cuts through the noise to examine the best-studied nutrients and botanicals, explains the mechanisms behind them, and shows how personalized supplementation — informed by your own lab work and health data — can move the needle where generic protocols fall flat.

---

Why Skin Barrier Integrity Is the Foundation of Eczema Management

The skin barrier in atopic dermatitis is structurally and functionally impaired. Mutations or reduced expression of filaggrin — a protein that holds skin cells together and retains moisture — are present in a significant proportion of eczema patients (Palmer et al., Nature Genetics 2006; PMID: 16550169). This breakdown allows allergens and microbes in while accelerating transepidermal water loss, triggering the itch-scratch cycle.

Several nutrients directly support filaggrin expression and ceramide synthesis, the lipid layer that forms the skin's waterproof seal:

• Vitamin D3: Keratinocytes (skin cells) express vitamin D receptors, and vitamin D directly upregulates filaggrin and antimicrobial peptides. A randomized controlled trial in children with eczema found that vitamin D3 supplementation at 1,000 IU/day for 60 days significantly reduced SCORAD (Severity Scoring of Atopic Dermatitis) scores compared to placebo (Javanbakht et al., Journal of Research in Medical Sciences 2011; PMID: 22091291). Many eczema patients are deficient — routine blood testing through a platform like Ones can identify your 25(OH)D level and calibrate your D3 dose accordingly. Ones pairs D3 with K2 (MK-7) to ensure proper calcium metabolism, a synergy backed by multiple cardiovascular and bone studies, and you can read more about vitamin D3 and K2 synergy in depth elsewhere on this site.

• Zinc: Zinc is essential for skin repair, immune modulation, and anti-inflammatory signaling. Low serum zinc has been observed in atopic dermatitis patients across multiple studies (NIH Office of Dietary Supplements). Zinc glycinate or zinc picolinate at 15–30 mg/day supports both barrier repair and reduces inflammatory cytokine production.

• Omega-3 Fatty Acids (EPA/DHA): EPA competes with arachidonic acid, reducing leukotriene B4 — a potent inflammatory mediator elevated in eczema. A meta-analysis of 19 trials found omega-3 supplementation to be associated with modest but consistent improvement in eczema severity scores (Bamford et al., Cochrane Database of Systematic Reviews 2013; doi.org/10.1002/14651858.CD008962.pub2). Doses studied range from 1.8 to 3.6 g EPA/DHA daily. For a deeper look at EPA-to-DHA ratios, see this omega-3 EPA DHA ratio guide.

---

Probiotics, the Gut-Skin Axis, and Atopic Dermatitis

The gut-skin axis is one of the most active areas of eczema research. The hypothesis is straightforward: a disrupted gut microbiome — characterized by reduced microbial diversity and overgrowth of pro-inflammatory species — amplifies systemic Th2 immune skewing, which drives atopic inflammation.

Probiotic evidence in eczema is nuanced. The strongest data involves Lactobacillus rhamnosus GG and specific Bifidobacterium strains used perinatally to reduce the incidence of eczema in high-risk infants (Wickens et al., Journal of Allergy and Clinical Immunology 2008; PMID: 18241682). In established eczema, a 2016 Cochrane review concluded that probiotics may reduce symptom severity in children, though effect sizes vary by strain and protocol (Foolad & Armstrong, Dermatologic Therapy 2014; PMID: 24552641).

The microbiome connection also explains why gut dysbiosis conditions like small intestinal bacterial overgrowth (SIBO) can worsen skin inflammation. SIBO increases intestinal permeability, allowing lipopolysaccharides (LPS) to enter systemic circulation and fuel the Th2 skew that underlies eczema. Similarly, candida overgrowth has been associated with heightened IgE sensitization and worsening atopic symptoms in susceptible individuals. While dedicated articles on supplements for SIBO and gut dysbiosis cover the GI side of this equation more fully, understanding that your eczema may have a gut-driven component is clinically important.

For eczema specifically, the evidence favors multi-strain probiotics containing L. rhamnosus and Bifidobacterium longum at 10–20 billion CFU daily for at least 8 weeks. Prebiotic fiber (inulin, FOS) to feed beneficial species is a logical adjunct.

---

N-Acetyl Cysteine (NAC), Quercetin, and the Inflammation Cascade

Beyond barrier support and the microbiome, eczema involves chronic oxidative stress and mast cell hyperreactivity. Two well-studied compounds address these upstream mechanisms:

N-Acetyl Cysteine (NAC): NAC is a precursor to glutathione, the body's primary intracellular antioxidant. Oxidative stress promotes NF-κB activation — the master switch for inflammatory gene expression — and NAC has been shown in preclinical models to attenuate this pathway in skin inflammation (Xu et al., Free Radical Biology and Medicine 2014; PMID: 24997485). Clinical doses studied range from 600–1,200 mg/day. Ones includes NAC as an individual formulated ingredient at clinically relevant doses.

Quercetin: A flavonoid found in onions, apples, and capers, quercetin inhibits histamine release from mast cells and basophils by suppressing IgE-mediated degranulation (Mlcek et al., Molecules 2016; PMID: 27187333). For individuals whose eczema is strongly driven by histamine sensitivity and allergic trigger, quercetin at 500–1,000 mg/day provides a complementary mechanism to antihistamine approaches. Ones's proprietary Histamine Support System Blend is specifically formulated for this mast cell / histamine-mediated pathway and may be relevant for eczema patients with overlapping allergic sensitivities.

---

Evening Primrose Oil, GLA, and the Fatty Acid Imbalance in Atopic Skin

Patients with atopic dermatitis show impaired delta-6-desaturase activity, the enzyme that converts linoleic acid to gamma-linolenic acid (GLA). GLA is a precursor to dihomo-GLA and subsequently to anti-inflammatory prostaglandin E1 (PGE1). This metabolic block creates a structural deficit in skin lipids.

Evening primrose oil (EPO) and borage oil are concentrated GLA sources. While early trial data was promising, a 2013 Cochrane review found that EPO and borage oil had inconsistent effects on eczema outcomes, with methodological limitations in most trials (Bamford et al., Cochrane Database of Systematic Reviews 2013; doi.org/10.1002/14651858.CD004416.pub2). The current consensus is that GLA supplementation may benefit a subset of patients — particularly those with confirmed low GLA metabolites — rather than the general eczema population. This underscores the importance of personalized testing over blanket recommendations.

---

Magnesium, Stress, and the HPA-Itch Connection

Stress is one of the most reliably reported eczema triggers. The mechanism involves cortisol-driven immune dysregulation, which tips the Th1/Th2 balance further toward Th2, and neuropeptide release (including substance P) that directly activates mast cells in skin. Magnesium deficiency — extraordinarily common in the American population — amplifies HPA axis reactivity and increases sensitivity to psychological stressors.

Magnesium glycinate, the most bioavailable and gut-tolerable form, has been shown to reduce cortisol response and improve sleep quality, which itself has bidirectional effects on skin barrier recovery (Nielsen et al., Magnesium Research 2010; PMID: 21199787). For those interested in magnesium's broader role in stress and sleep, the optimal magnesium glycinate dosage guide covers the clinical ranges in detail. Ones's Magnesium Complex uses glycinate alongside other synergistic forms, dosed to clinical ranges based on your intake history and serum magnesium data.

---

Key Supplement Comparison for Eczema

---

What This Means for Your Formula: How Ones Addresses Eczema

Generic supplement stacks for eczema ignore what makes your presentation unique: your vitamin D level, your gut microbiome status, your stress hormone patterns, and your inflammatory markers. Ones's AI health practitioner synthesizes your blood work, wearable data, and health history to build a formula that addresses your specific drivers — not a best-guess stack designed for the average patient.

For eczema-relevant support, Ones draws on several specific ingredients and blends:

1. Vitamin D3 + K2 (MK-7): Ones includes vitamin D3 paired with K2 in MK-7 form, calibrated to your measured 25(OH)D serum level. This avoids both under-dosing (leaving deficiency untreated) and over-supplementation. The pairing of K2 MK-7 ensures K-dependent proteins are activated, a distinction that matters for overall inflammatory regulation.

1. Omega-3 (EPA/DHA): Ones formulates EPA and DHA at doses calibrated to clinical evidence — not the minimal amounts found in many commercial multivitamins — and adjusts based on dietary intake history. The anti-inflammatory prostaglandin shift from adequate EPA is one of the most evidence-backed mechanisms for reducing atopic skin inflammation.

1. NAC and Histamine Support System Blend: For individuals whose eczema overlaps with histamine reactivity, immune hypersensitivity, or oxidative stress patterns visible in lab data, Ones can include NAC at clinical doses alongside its proprietary Histamine Support blend. The Histamine Support System Blend is designed specifically for the mast cell and histamine-mediated inflammatory pathway — a distinct mechanism that standard eczema protocols rarely address.

Because Ones formulas come in 6, 9, or 12-capsule plans, your eczema-relevant ingredients can be combined with support for any co-occurring issues — whether that's adrenal stress, gut dysbiosis, or suboptimal thyroid function — without forcing you to manage a dozen separate bottles. You can also explore how Ones approaches clinical evidence for ashwagandha as part of adrenal and cortisol support that may benefit stress-triggered eczema flares.

Compared to platforms like Ritual (which offers fixed-formula multivitamins) or Thorne (practitioner-grade single ingredients without AI-driven personalization), Ones's approach combines the rigor of practitioner-grade dosing with the intelligence of an AI system that reads your actual biomarkers — not a lifestyle quiz.

---

Key Takeaways

• Eczema is a systemic condition rooted in skin barrier dysfunction, immune Th2 skewing, gut dysbiosis, and oxidative stress — effective supplementation should address multiple pathways, not just skin surface symptoms.
• Vitamin D3, omega-3 fatty acids, zinc, and probiotics have the strongest clinical evidence for reducing eczema severity; dosing to clinical ranges — not RDA minimums — is critical.
• Gut health is inseparable from skin health: SIBO, candida overgrowth, and low microbial diversity can all amplify atopic inflammation via increased intestinal permeability and LPS-driven immune activation.
• NAC and quercetin target upstream mechanisms (oxidative stress and mast cell histamine release) that standard eczema protocols overlook, and may be especially useful for individuals with overlapping histamine sensitivity.
• Magnesium glycinate addresses the cortisol-itch cycle and sleep disruption that perpetuate eczema flares in stress-sensitive individuals.
• Personalized testing matters: GLA (evening primrose oil) and some other supplements only benefit subsets of patients — knowing your actual biomarkers before building a stack prevents wasted money and missed targets. Platforms like Ones use lab data and wearable insights to calibrate your formula to your biology, not a population average.

Always consult a licensed healthcare provider before starting or changing any supplement protocol, particularly if you are managing eczema alongside other medical conditions or medications.